Founders Capital Management - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Founders Capital Management ownership history of NOVARTIS A G
ValueSharesWeighting
Q2 2018$925,000
-66.1%
12,246
-63.7%
0.81%
-64.6%
Q1 2018$2,726,000
-3.7%
33,7200.0%2.30%
-2.2%
Q4 2017$2,831,000
-2.0%
33,720
+0.2%
2.35%
-2.0%
Q3 2017$2,890,000
+7.6%
33,660
+4.6%
2.40%
+0.6%
Q2 2017$2,686,000
+2.4%
32,175
-8.9%
2.38%
+0.9%
Q1 2017$2,623,00035,3202.36%
Other shareholders
NOVARTIS A G shareholders Q3 2023
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders